Sep 23, 2020 FCA publishes guidance on its approach to cannabis-related companies looking to list in the UK By Dylan Kennett On 18 September the published guidance on the listing of cannabis-based businesses onto public stock exchanges in the UK. We consider the...
Sep 18, 2020 Digital Therapeutics - evolution and entry into mainstream healthcare By Marco de Morpurgo Research undertaken by DLA Piper's Life Sciences sector in conjunction with The Lawyer seeks to understand the current developments in...
Sep 10, 2020 Changes to Australian medical device laws delayed By Greg Bodulovic Alexandra Moore As the medical and healthcare sectors remain firmly focused on tackling the many and ongoing challenges of COVID-19, the Australian...
Sep 10, 2020 The wait is not over for approved medicinal CBD in Australia By Greg Bodulovic We previously reported in our article “Developments in Australian CBD market” that the Pharmaceutical Benefits Advisory Committee (PBAC)...